March 26, 2024 | Client News
NEW YORK, NY / ACCESSWIRE / March 26, 2024 / 1847 Holdings LLC (“1847” or the “Company”) (NYSE American:EFSH), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, filed a Request for Withdrawal with the SEC on March 22, 2024 relating to withdrawal of the Company’s Registration Statement on Form […]
March 26, 2024 | Client News
SNK01 autologous NK cell therapy demonstrated a positive effect on cerebral spinal fluid (“CSF”) and plasma Tau proteins in Alzheimer’s patients. The additional Phase 1 SNK01 trial data suggest clinical activity regarding cognitive function in patients with advanced Alzheimer’s disease in addition to previously disclosed positive effects on amyloid protein and neuroinflammation biomarkers. SANTA ANA, […]
March 22, 2024 | Client News
Ocular Pain Relief showed statistically significant improvement as early as day 15 and the benefit was durable throughout the trial. Conjunctival Staining improved as early as day 29 with a durable benefit throughout the trial. Tear Film Break-up Time showed statistically significant improvement as early as day 15 with the benefit durable for the remainder […]
March 22, 2024 | Client News
Participants Frank Pogubila; IR; Sadot Group, Inc. Michael Roper; CEO; Sadot Group, Inc. Jennifer Black; CFO; Sadot Group, Inc. Benjamin Petel; Director; Sadot Group, Inc. Aaron Grey; Analyst; Alliance Global Partners Tom Kerr; Analyst; Zacks Small Cap Research Presentation Operator Welcome to the second Group, Inc. Q4 fiscal year 2023 earnings conference call. Today’s call […]
March 22, 2024 | Client News
Vancouver, British Columbia –News Direct– BYND Cannasoft Enterprises ASHKELON, Israel and VANCOUVER, British Columbia – TheNewswire – March 22, 2024 – BYND Cannasoft Enterprises Inc. (Nasdaq:BCAN) (“BYND Cannasoft” or the “Company”) an Israeli-based integrated software and cannabis company, today announced that the previously announced 1-for-190 reverse stock split of its outstanding shares of common stock […]
March 21, 2024 | Client News
2023 Revenue Rises to $726.7 million from $161.7 million in 2022 Adjusted EBITDA Rises to $0.1 million vs. $2.0 million loss Year over Year Engages Third Party to Explore the Potential Divestment of its Restaurant and Food Prep Assets FORT WORTH, TX / ACCESSWIRE / March 20, 2024 / Sadot Group Inc. (NASDAQ:SDOT) (the “Sadot Group” […]
March 21, 2024 | Client News
–Phase 2 OK-101 efficacy data to be released March 22nd, 2024- -KOL Event to be held on April 9th, 2024 at 12 PM ET- LONDON and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease […]
March 21, 2024 | Client News
Vol State is Fifth Contract Win Since Introducing No Setup-fee Plan DETROIT, MI / ACCESSWIRE / March 21, 2024 / Amesite Inc. (NASDAQ:AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces a five-year (5) partnership with Volunteer State Community College to deliver non degreed AI and […]
March 21, 2024 | Client News
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that MitoCareX Bio […]
